PT Darya-Varia Laboratoria operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Darya-Varia Laboratoria with three other
pharmaceutical manufacturers in Asia:
Lansen Pharmaceutical Holdings Limited
sales of 591.37 million Chinese Renmimbi [US$95.21 million]
of which 64%
was Rheumatic Specialty Prescription Western),
Biofermin Pharmaceutical Company Limited
(9.50 billion Japanese Yen [US$93.51 million]
of which 57%
was New Biofermin S), and
based in India
(5.83 billion Indian Rupees [US$96.95 million]
of which 95%
PT Darya-Varia Laboratoria reported sales of 1.09 trillion Indonesian Rupiahs (US$95.25 million)
December of 2012.
increase of 11.8%
versus 2011, when the company's sales were 972.30 billion Indonesian Rupiahs.
Sales at PT Darya-Varia Laboratoria have increased during each of the previous five years
(and since 2007, sales have increased a total of 113%).
Sales of Toll Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
53.0% in 2012, from
129.42 billion Indonesian Rupiahs to 198.00 billion Indonesian Rupiahs.